Literature DB >> 27353163

Synthesis and biological evaluation of lipophilic teicoplanin pseudoaglycon derivatives containing a substituted triazole function.

Zsolt Szűcs1, Magdolna Csávás1, Erzsébet Rőth1, Anikó Borbás1, Gyula Batta2, Florent Perret3, Eszter Ostorházi4, Réka Szatmári4, Evelien Vanderlinden5, Lieve Naesens5, Pál Herczegh1.   

Abstract

A series of lipophilic teicoplanin pseudoaglycon derivatives, including alkyl-, aryl-, calixarene- and protected sugar-containing conjugates, were prepared using azide-alkyne click chemistry. Out of the conditions applied, the CuSO4-ascorbate reagent system proved to be more efficient than the Cu(I)I-Et3N-mediated reaction. Some of the new compounds have high in vitro activity against glycopeptide-resistant Gram-positive bacteria, including vanA-positive Enterococcus faecalis. A few of them also display promising in vitro anti-influenza activity.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27353163     DOI: 10.1038/ja.2016.80

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  23 in total

1.  Oritavancin disrupts membrane integrity of Staphylococcus aureus and vancomycin-resistant enterococci to effect rapid bacterial killing.

Authors:  Adam Belley; Geoffrey A McKay; Francis F Arhin; Ingrid Sarmiento; Sylvain Beaulieu; Ibthihal Fadhil; Thomas R Parr; Gregory Moeck
Journal:  Antimicrob Agents Chemother       Date:  2010-09-27       Impact factor: 5.191

2.  Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms.

Authors:  F Bager; M Madsen; J Christensen; F M Aarestrup
Journal:  Prev Vet Med       Date:  1997-07       Impact factor: 2.670

3.  Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin.

Authors:  Evelien Vanderlinden; Fusun Göktas; Zafer Cesur; Matheus Froeyen; Mark L Reed; Charles J Russell; Nesrin Cesur; Lieve Naesens
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

4.  Easy and selective method for the synthesis of various mono-O-functionalized calix[4]arenes: de-O-functionalization using TiCl4.

Authors:  Joackim Bois; Jeff Espinas; Ulrich Darbost; Caroline Felix; Christian Duchamp; Denis Bouchu; Mostafa Taoufik; Isabelle Bonnamour
Journal:  J Org Chem       Date:  2010-10-20       Impact factor: 4.354

5.  Synthesis of isoindole and benzoisoindole derivatives of teicoplanin pseudoaglycon with remarkable antibacterial and antiviral activities.

Authors:  Attila Sipos; Zsolt Török; Erzsébet Rőth; Attila Kiss-Szikszai; Gyula Batta; Ilona Bereczki; Zsolt Fejes; Anikó Borbás; Eszter Ostorházi; Ferenc Rozgonyi; Lieve Naesens; Pál Herczegh
Journal:  Bioorg Med Chem Lett       Date:  2012-09-29       Impact factor: 2.823

6.  Diazo transfer-click reaction route to new, lipophilic teicoplanin and ristocetin aglycon derivatives with high antibacterial and anti-influenza virus activity: an aggregation and receptor binding study.

Authors:  Gábor Pintér; Gyula Batta; Sándor Kéki; Attila Mándi; István Komáromi; Krisztina Takács-Novák; Ferenc Sztaricskai; Erzsébet Röth; Eszter Ostorházi; Ferenc Rozgonyi; Lieve Naesens; Pál Herczegh
Journal:  J Med Chem       Date:  2009-10-08       Impact factor: 7.446

7.  In vitro studies of the pharmacodynamics of teicoplanin against Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecium.

Authors:  I Odenholt; E Löwdin; O Cars
Journal:  Clin Microbiol Infect       Date:  2003-09       Impact factor: 8.067

8.  Telavancin: A novel lipoglycopeptide antibiotic.

Authors:  S E Damodaran; S Madhan
Journal:  J Pharmacol Pharmacother       Date:  2011-04

9.  A convenient method for the synthesis of (prop-2-ynyloxy)benzene derivatives via reaction with propargyl bromide, their optimization, scope and biological evaluation.

Authors:  Tannaza Batool; Nasir Rasool; Yasmeen Gull; Mnaza Noreen; Faiz-ul-Hassan Nasim; Asma Yaqoob; Muhammad Zubair; Usman Ali Rana; Salah Ud-Din Khan; M Zia-Ul-Haq; Hawa Z E Jaafar
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

Review 10.  Old and New Glycopeptide Antibiotics: Action and Resistance.

Authors:  Elisa Binda; Flavia Marinelli; Giorgia Letizia Marcone
Journal:  Antibiotics (Basel)       Date:  2014-11-04
View more
  6 in total

1.  N-Terminal guanidine derivatives of teicoplanin antibiotics strongly active against glycopeptide resistant Enterococcus faecium.

Authors:  Zsolt Szűcs; Ilona Bereczki; Erzsébet Rőth; Márton Milánkovits; Eszter Ostorházi; Gyula Batta; Lajos Nagy; Zsuzsanna Dombrádi; Anikó Borbás; Pál Herczegh
Journal:  J Antibiot (Tokyo)       Date:  2020-05-15       Impact factor: 2.649

2.  Developments in Glycopeptide Antibiotics.

Authors:  Mark A T Blaskovich; Karl A Hansford; Mark S Butler; ZhiGuang Jia; Alan E Mark; Matthew A Cooper
Journal:  ACS Infect Dis       Date:  2018-02-19       Impact factor: 5.084

3.  VanZ Reduces the Binding of Lipoglycopeptide Antibiotics to Staphylococcus aureus and Streptococcus pneumoniae Cells.

Authors:  Vladimir Vimberg; Leona Zieglerová; Karolína Buriánková; Pavel Branny; Gabriela Balíková Novotná
Journal:  Front Microbiol       Date:  2020-04-03       Impact factor: 5.640

4.  Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents.

Authors:  Zsolt Szűcs; Viktor Kelemen; Son Le Thai; Magdolna Csávás; Erzsébet Rőth; Gyula Batta; Annelies Stevaert; Evelien Vanderlinden; Lieve Naesens; Pál Herczegh; Anikó Borbás
Journal:  Eur J Med Chem       Date:  2018-08-22       Impact factor: 6.514

5.  Reprogramming of the Antibacterial Drug Vancomycin Results in Potent Antiviral Agents Devoid of Antibacterial Activity.

Authors:  Zsolt Szűcs; Lieve Naesens; Annelies Stevaert; Eszter Ostorházi; Gyula Batta; Pál Herczegh; Anikó Borbás
Journal:  Pharmaceuticals (Basel)       Date:  2020-06-29

Review 6.  Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014-2022.

Authors:  Emma van Groesen; Paolo Innocenti; Nathaniel I Martin
Journal:  ACS Infect Dis       Date:  2022-07-27       Impact factor: 5.578

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.